Non-oxime pyrazole based inhibitors of B-Raf kinase.
Newhouse, B.J., Hansen, J.D., Grina, J., Welch, M., Topalov, G., Littman, N., Callejo, M., Martinson, M., Galbraith, S., Laird, E.R., Brandhuber, B.J., Vigers, G., Morales, T., Woessner, R., Randolph, N., Lyssikatos, J., Olivero, A.(2011) Bioorg Med Chem Lett 21: 3488-3492
- PubMed: 21536432 
- DOI: https://doi.org/10.1016/j.bmcl.2010.12.038
- Primary Citation of Related Structures:  
3PSD - PubMed Abstract: 
The synthesis and biological evaluation of non-oxime pyrazole based B-Raf inhibitors is reported. Several oxime replacements have been prepared and have shown excellent enzyme activity. Further optimization of fused pyrazole 2a led to compound 38, a selective and potent B-Raf inhibitor.
Organizational Affiliation: 
Array BioPharma, 3200 Walnut Street, Boulder, CO 80301, United States. bnewhouse@arraybiopharma.com